Blueprint Medicines Corporation Analytics - Traffic, Statistics and Competitor Tracking


Blueprint Medicines Corporation Website Screenshot

http://www.blueprintmedicines.com

Blueprint Medicines Corporation Company Intro

Protein kinases (enzymes that modify the functions of proteins) are critical to controlling biochemical pathways and are involved in many hallmarks of tumor biology – yet currently approved drugs focus on less than 5% of known kinases.

Industry

Healthcare

Blueprint Medicines Corporation Headquaters

45 Sidney Street
Cambridge,02139
United States


Blueprint Medicines Corporation Share price

02 Dec 2021 09:43 GMT

$97.70

1.5 (1.56 %)


Blueprint Medicines Corporation Market cap

$5.603 B


WMC RANKING

2021

Blueprint Medicines Corporation # 85

Biotechnology

Latest Blueprint Medicines Corporation News

News 01 Dec 2021

Here is why ImmunoGen Inc. (IMGN) stock went down in the after-hours after good early gains?

ImmunoGen Inc. (IMGN) shares surged 29.89% in regular trading but later declined 5.03% in after-hours on Tuesday and closed at $5.86.

News 01 Dec 2021

FY2025 Earnings Estimate for Blueprint Medicines Co. Issued By Wedbush (NASDAQ:BPMC)

Blueprint Medicines Co. (NASDAQ:BPMC) - Analysts at Wedbush dropped their FY2025 earnings estimates for Blueprint Medicines in a report released on Monday,...

News 01 Dec 2021

-$0.75 EPS Expected for Blueprint Medicines Co. (NASDAQ:BPMC) This Quarter

Wall Street analysts predict that Blueprint Medicines Co. (NASDAQ:BPMC) will announce earnings per share of ($0.75) for the current quarter, Zacks reports.


WMC Market Score


WMC Market to Revenue Score


Blueprint Medicines Corporation Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Blueprint Medicines Corporation USD $809,144 $486,514 $325,123 $56,030B 85
Regeneron Pharmaceuticals, Inc. USD $9,197,600 $3,997,800 $4,003,800 $685,150B 1
Vertex Pharmaceuticals Incorporated USD $6,414,881 $2,617,257 $2,762,032 $515,660B 2
Alexion Pharmaceuticals, Inc. USD $6,261,601 $2,747,200 $681,800 $ 3
Incyte Corporation USD $2,702,913 $2,048,306 $478,480 $148,930B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Blueprint Medicines Corporation Social Followers vs Top 4 Industry Competitors



Blueprint Medicines Corporation Post vs Top 4 Industry Competitors




Blueprint Medicines Corporation Digital Footprint By Size vs Top 4 Industry Competitors



Blueprint Medicines Corporation Digital Footprint By Change Rate vs Top 4 Industry Competitors



Blueprint Medicines Corporation WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Blueprint Medicines Corporation 8.80 10.99 0.06 0 0 0 4.36
Regeneron Pharmaceuticals, Inc. 100 25.50 16.15 100 0 0 54.46
Vertex Pharmaceuticals Incorporated 69.75 35.68 8.95 86 0 0 50.16
Alexion Pharmaceuticals, Inc. 68.08 100 100 60 0 0 100
Incyte Corporation 29.39 5.03 0.04 2 0 0 2.88

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries